药物发现技术
市场调查报告书
商品编码
1550158

药物发现技术

Drug Discovery Technologies

出版日期: | 出版商: BCC Research | 英文 192 Pages | 订单完成后即时交付

价格

全球药物发现技术市场规模预计将从 2024 年的1,119 亿美元增至 2029 年底的 1,970 亿美元,预测期内复合年增长率为 12.0%。

生物分析仪器产业预计将从2024年的300亿美元成长到2029年终的503亿美元,复合年增长率为10.9%。此外,高通量筛检产业预计将从 2024 年的 250 亿美元成长到 2029年终的439 亿美元,复合年增长率为 11.9%。

该报告调查了全球药物发现技术市场,并提供了市场概况、市场影响因素和市场机会分析、新兴技术和技术发展趋势、市场规模趋势和预测,以及各个细分市场和地区的详细分析、竞争格局。

目录

第一章执行摘要

  • 市场展望
  • 调查范围
  • 市场概况

第二章 市场概况

  • 概述
  • 波特五力分析

第三章市场动态

  • 市场动态
  • 市场驱动因素
  • 药物发现中的高内涵筛检(HCS)技术
  • 技术进步
  • 个性化医疗需求
  • 慢性病和免疫疾病盛行率上升
  • 老年人口增加
  • 研究经费的可用性
  • 市场限制因素
  • 药物发现过程和设备成本
  • 严格规定
  • 更深入了解分子机制
  • 市场机会
  • 人工智慧在药物发现的潜力

第四章新兴技术

  • 概述
  • AI

第五章市场区隔分析

  • 细分细分
  • 全球药物发现技术市场:依技术分类
  • 全球市场预测
  • 高通量筛检(HTS)
  • 生物分析设备
  • 基因组学
  • 蛋白质体学
  • 基于细胞的测定和试剂
  • 生物资讯学
  • 其他的
  • 全球药物发现技术市场:依疾病分类
  • 全球市场规模及预测
  • 心臟病
  • 神经退化性疾病
  • 免疫疾病
  • 其他的
  • 全球药物发现技术市场:按最终用户划分
  • 全球市场规模及预测
  • 生物製药公司
  • 研究/学术
  • CRO
  • 地域分布
  • 全球药物发现技术市场:按地区划分
  • 全球市场规模及预测
  • 北美洲
  • 欧洲
  • 亚太地区
  • 其他的

第六章 竞争讯息

  • 竞争格局
  • 公司市场占有率分析
  • SWOT分析

第七章 给药技术市场的永续性:ESG 视角

  • ESG:简介
  • 药物发现技术产业的永续性
  • ESG观点
  • 环境影响
  • 社会影响
  • 管治影响

第8章附录

  • 调查方法
  • 简称
  • 来源
  • 公司简介
  • AGILENT TECHNOLOGIES INC.
  • BIO-RAD LABORATORIES INC.
  • BRUKER
  • CHARLES RIVER LABORATORIES
  • DANAHER CORP.
  • ILLUMINA INC.
  • PROMEGA CORP.
  • QIAGEN
  • REVVITY
  • THERMO FISHER SCIENTIFIC INC.
Product Code: BIO020H

The global market for drug discovery technologies is expected to grow from $111.9 billion in 2024 and is projected to reach $197.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.0% during the forecast period of 2024 to 2029.

The bioanalytical instruments market for drug discovery technologies is expected to grow from $30.0 billion in 2024 and is projected to reach $50.3 billion by the end of 2029, at a CAGR of 10.9% during the forecast period of 2024 to 2029.

The high-throughput screening market for drug discovery technologies is expected to grow from $25.0 billion in 2024 and is projected to reach $43.9 billion by the end of 2029, at a CAGR of 11.9% during the forecast period of 2024 to 2029.

Report Scope:

This report provides detailed information on the drug discovery technologies market. This report analyzes the market trends of drug discovery technologies with data from 2023, estimates from 2024, projections of compound annual growth rates (CAGRs) through 2029 (forecast period 2024-2029), and regional markets of drug discovery technologies. This report highlights drug discovery technologies' current and future market potential and gives a detailed analysis of the competitive environment. The report covers regulatory scenarios, drivers, restraints, and opportunities. This report also covers market projections for 2029 and the market share for key market players.

The market scope in this report is segmented into technologies and applications. Based on technologies, this report covers high-throughput screening (HTS), bioanalytical instruments, cell-based assays and reagents, genomics, bioinformatics, proteomics, and others, such as combinatorial chemistry, metabolomics, nanotechnology, and system biology. These technologies are further classified into subcategories for this report. The market is segmented based on application to oncology, cardiovascular diseases, neurodegenerative diseases, immunological diseases, and others.

The market has been segmented into North America, Europe, Asia-Pacific, and other world regions. The regional segment covers a detailed analysis of major countries such as the U.S., Canada, Germany, the U.K., Italy, Spain, France, Japan, China, South Korea, Australia, and India. For market estimates, data is provided for 2023, with forecasts for 2024 and projections for 2029.

The report's goals include:

  • Analyzing technologies and applications.
  • Analyzing global market size and segmentation.
  • Identifying market constraints and drivers.
  • Providing detailed market forecasts through 2029.
  • Assessing market shares, competitiveness, and industry structure.
  • Identifying potential long-term impacts on the drug discovery technologies market.

Report Includes:

  • 104 data tables and 34 additional tables
  • An analysis of the current and future global markets for drug discovery technologies
  • Analyses of global market trends, with market revenue data (sales figures) for 2021-2023, estimates for 2024, and projected CAGRs through 2029
  • Estimates of the market size and revenue forecasts for the global market for drug discovery technologies, with market share analysis by therapeutics, application, end user and region
  • Discussion of bioinformatics as a platform for drug discovery
  • A comparison between proteomics and genomics drug discovery technology
  • Comparative assessment of pharmacokinetics and pharmacodynamics, and classification of the techniques used in drug discovery
  • Discussions of the market dynamics, opportunities and challenges, as well as emerging technologies
  • Overview of the sustainability trends and ESG developments in the industry, with emphasis on the ESG practices of leading companies, their ESG rankings, and consumer attitudes
  • Competitive intelligence, including companies' market shares, recent M&A activity and venture funding
  • Profiles of the leading companies, including Thermo Fisher Scientific Inc., Danaher Corp., Agilent Technologies Inc., Illumina, and Charles River Laboratories.

Table of Contents

Chapter 1 Executive Summary

  • Market Outlook
  • Scope of the Report
  • Market Summary

Chapter 2 Market Overview

  • Overview
  • Porter's Five Forces Analysis
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Potential for New Entrants
  • Threat of Substitutes
  • Competitiveness in the Industry

Chapter 3 Market Dynamics

  • Market Dynamics
  • Market Drivers
  • High-Content Screening (HCS) Techniques in Drug Discovery
  • Technological Advances
  • Demand for Personalized Medicine
  • Rising Prevalence of Chronic and Immunological Diseases
  • Growing Elderly Population
  • Availability of Research Funds
  • Market Restraints
  • Cost of the Drug Discovery Process and Instruments
  • Stringent Regulations
  • Better Understanding of Molecular Mechanisms
  • Market Opportunities
  • Potential for AI in Drug Discovery

Chapter 4 Emerging Technologies

  • Overview
  • AI

Chapter 5 Market Segmentation Analysis

  • Segmentation Breakdown
  • Global Market for Drug Discovery Technologies, by Technology
  • Global Market Forecast
  • High-Throughput Screening (HTS)
  • Bioanalytical Instruments
  • Genomics
  • Proteomics
  • Cell-Based Assays and Reagents
  • Bioinformatics
  • Other Technologies
  • Market for Drug Discovery Technologies, by Disease Application
  • Global Market Size and Forecast
  • Oncology
  • Cardiology
  • Neurodegenerative Diseases
  • Immunological Diseases
  • Other Diseases
  • Global Market for Drug Discovery Technologies, by End User
  • Global Market Size and Forecast
  • Biopharmaceutical Companies
  • Research and Academia
  • Contract Research Organizations (CROs)
  • Geographic Breakdown
  • Global Market for Drug Discovery Technologies, by Region
  • Global Market Size and Forecast
  • North America
  • Europe
  • Asia-Pacific
  • Rest of World

Chapter 6 Competitive Intelligence

  • Competitive Landscape
  • Analysis of Companies' Market Shares
  • SWOT Analysis
  • Strengths
  • Challenges
  • Opportunities
  • Threats

Chapter 7 Sustainability in the Drug Delivery Technologies Market: An ESG Perspective

  • Introduction to ESG
  • Sustainability in the Drug Discovery Technologies Industry
  • ESG Perspective
  • Environmental Impact
  • Social Impact
  • Governance Impact

Chapter 8 Appendix

  • Methodology
  • Abbreviations
  • Sources
  • Company Profiles
  • AGILENT TECHNOLOGIES INC.
  • BIO-RAD LABORATORIES INC.
  • BRUKER
  • CHARLES RIVER LABORATORIES
  • DANAHER CORP.
  • ILLUMINA INC.
  • PROMEGA CORP.
  • QIAGEN
  • REVVITY
  • THERMO FISHER SCIENTIFIC INC.

List of Tables

  • Summary Table : Global Market for Drug Discovery Technologies, by Technology, Through 2029
  • Table 1 : Porter's Five Forces Analysis of the Drug Discovery Technologies Market
  • Table 2 : Global Diabetes Prevalence, Estimates and Projections, 2021-2045
  • Table 3 : Global Prevalence of Multiple Sclerosis, by WHO Region, 2013 and 2020
  • Table 4 : Global HIV Epidemic, by Age Group, 2023
  • Table 5 : Global Population Growth, by Age Group, Through 2050
  • Table 6 : Global Market for Drug Discovery Technologies, by Technology, Through 2029
  • Table 7 : Global Market for HTS in Drug Discovery, by Region, Through 2029
  • Table 8 : Global Market for Bioanalytical Instruments in Drug Discovery, by Product Type, Through 2029
  • Table 9 : Global Market for Bioanalytical Instruments in Drug Discovery, by Region, Through 2029
  • Table 10 : Global Market for Genomics in Drug Discovery, by Product Type, Through 2029
  • Table 11 : Global Market for Genomics in Drug Discovery, by Region, Through 2029
  • Table 12 : Protein Microarrays and Their Functions
  • Table 13 : Global Market for Proteomics in Drug Discovery, by Product Type, Through 2029
  • Table 14 : Global Market for Proteomics in Drug Discovery, by Region, Through 2029
  • Table 15 : Cell Biology Reagents and Their Functions
  • Table 16 : Global Market for Cell-Based Assays and Reagents in Drug Discovery, by Product Type, Through 2029
  • Table 17 : Global Market for Cell-based Assays and Reagents in Drug Discovery, by Region, Through 2029
  • Table 18 : Global Market for Bioinformatics in Drug Discovery, by Region, Through 2029
  • Table 19 : Comparison of Solid-Phase and Solution-Phase Synthesis
  • Table 20 : Global Market for Other Technologies in Drug Discovery, by Region, Through 2029
  • Table 21 : Global Market for Drug Discovery Technologies, by Application, Through 2029
  • Table 22 : Global Market for Drug Discovery Technologies in Oncology, by Region, Through 2029
  • Table 23 : Global Market for Drug Discovery Technologies in Cardiology, by Region, Through 2029
  • Table 24 : Global Market for Drug Discovery Technologies in Neurodegenerative Diseases, by Region, Through 2029
  • Table 25 : Global Market for Drug Discovery Technologies in Immunological Diseases, by Region, Through 2029
  • Table 26 : Global Market for Drug Discovery Technologies in Other Diseases, by Region, Through 2029
  • Table 27 : Global Market for Drug Discovery Technologies, by End User, Through 2029
  • Table 28 : Global Market for Drug Discovery Technologies in Biopharma Companies, by Region, Through 2029
  • Table 29 : Global Market for Drug Discovery Technologies in Research and Academia, by Region, Through 2029
  • Table 30 : Global Market for Drug Discovery Technologies in CROs, by Region, Through 2029
  • Table 31 : Global Market for Drug Discovery Technologies, by Region, Through 2029
  • Table 32 : North American Market for Drug Discovery Technologies, by Technology, Through 2029
  • Table 33 : North American Market for Drug Discovery Technologies, by Application, Through 2029
  • Table 34 : North American Market for Drug Discovery Technologies, by End User, Through 2029
  • Table 35 : North American Market for Drug Discovery Technologies, by Country, Through 2029
  • Table 36 : U.S. Market for Drug Discovery Technologies, by Technology, Through 2029
  • Table 37 : U.S. Market for Drug Discovery Technologies, by Application, Through 2029
  • Table 38 : U.S. Market for Drug Discovery Technologies, by End User, Through 2029
  • Table 39 : Canadian Market for Drug Discovery Technologies, by Technology, Through 2029
  • Table 40 : Canadian Market for Drug Discovery Technologies, by Application, Through 2029
  • Table 41 : Canadian Market for Drug Discovery Technologies, by End User, Through 2029
  • Table 42 : Mexican Market for Drug Discovery Technologies, by Technology, Through 2029
  • Table 43 : Mexican Market for Drug Discovery Technologies, by Application, Through 2029
  • Table 44 : Mexican Market for Drug Discovery Technologies, by End User, Through 2029
  • Table 45 : European Market for Drug Discovery Technologies, by Technology, Through 2029
  • Table 46 : European Market for Drug Discovery Technologies, by Application, Through 2029
  • Table 47 : European Market for Drug Discovery Technologies, by End User, Through 2029
  • Table 48 : European Market for Drug Discovery Technologies, by Country, Through 2029
  • Table 49 : German Market for Drug Discovery Technologies, by Technology, Through 2029
  • Table 50 : German Market for Drug Discovery Technologies, by Application, Through 2029
  • Table 51 : German Market for Drug Discovery Technologies, by End User, Through 2029
  • Table 52 : U.K. Market for Drug Discovery Technologies, by Technology, Through 2029
  • Table 53 : U.K. Market for Drug Discovery Technologies, by Application, Through 2029
  • Table 54 : U.K. Market for Drug Discovery Technologies, by End User, Through 2029
  • Table 55 : French Market for Drug Discovery Technologies, by Technology, Through 2029
  • Table 56 : French Market for Drug Discovery Technologies, by Application, Through 2029
  • Table 57 : French Market for Drug Discovery Technologies, by End User, Through 2029
  • Table 58 : Italian Market for Drug Discovery Technologies, by Technology, Through 2029
  • Table 59 : Italian Market for Drug Discovery Technologies, by Application, Through 2029
  • Table 60 : Italian Market for Drug Discovery Technologies, by End User, Through 2029
  • Table 61 : Spanish Market for Drug Discovery Technologies, by Technology, Through 2029
  • Table 62 : Spanish Market for Drug Discovery Technologies, by Application, Through 2029
  • Table 63 : Spanish Market for Drug Discovery Technologies, by End User, Through 2029
  • Table 64 : Rest of Europe Market for Drug Discovery Technologies, by Technology, Through 2029
  • Table 65 : Rest of Europe Market for Drug Discovery Technologies, by Application, Through 2029
  • Table 66 : Rest of Europe Market for Drug Discovery Technologies, by End User, Through 2029
  • Table 67 : Asia-Pacific Market for Drug Discovery Technologies, by Technology, Through 2029
  • Table 68 : Asia-Pacific Market for Drug Discovery Technologies, by Application, Through 2029
  • Table 69 : Asia-Pacific Market for Drug Discovery Technologies, by End User, Through 2029
  • Table 70 : Asia-Pacific Market for Drug Discovery Technologies, by Country, Through 2029
  • Table 71 : Chinese Market for Drug Discovery Technologies, by Technology, Through 2029
  • Table 72 : Chinese Market for Drug Discovery Technologies, by Application, Through 2029
  • Table 73 : Chinese Market for Drug Discovery Technologies, by End User, Through 2029
  • Table 74 : Japanese Market for Drug Discovery Technologies, by Technology, Through 2029
  • Table 75 : Japanese Market for Drug Discovery Technologies, by Application, Through 2029
  • Table 76 : Japanese Market for Drug Discovery Technologies, by End User, Through 2029
  • Table 77 : Indian Market for Drug Discovery Technologies, by Technology, Through 2029
  • Table 78 : Indian Market for Drug Discovery Technologies, by Application, Through 2029
  • Table 79 : Indian Market for Drug Discovery Technologies, by End User, Through 2029
  • Table 80 : South Korean Market for Drug Discovery Technologies, by Technology, Through 2029
  • Table 81 : South Korean Market for Drug Discovery Technologies, by Application, Through 2029
  • Table 82 : South Korean Market for Drug Discovery Technologies, by End User, Through 2029
  • Table 83 : Australian Market for Drug Discovery Technologies, by Technology, Through 2029
  • Table 84 : Australian Market for Drug Discovery Technologies, by Application, Through 2029
  • Table 85 : Australian Market for Drug Discovery Technologies, by End User, Through 2029
  • Table 86 : Rest of Asia-Pacific Market for Drug Discovery Technologies, by Technology, Through 2029
  • Table 87 : Rest of Asia-Pacific Market for Drug Discovery Technologies, by Application, Through 2029
  • Table 88 : Rest of Asia-Pacific Market for Drug Discovery Technologies, by End User, Through 2029
  • Table 89 : RoW Market for Drug Discovery Technologies, by Technology, Through 2029
  • Table 90 : RoW Market for Drug Discovery Technologies, by Application, Through 2029
  • Table 91 : RoW Market for Drug Discovery Technologies, by End User, Through 2029
  • Table 92 : RoW Market for Drug Discovery Technologies, by Sub-Region, Through 2029
  • Table 93 : South American Market for Drug Discovery Technologies, by Technology, Through 2029
  • Table 94 : South American Market for Drug Discovery Technologies, by Application, Through 2029
  • Table 95 : South American Market for Drug Discovery Technologies, by End User, Through 2029
  • Table 96 : MEA Market for Drug Discovery Technologies, by Technology, Through 2029
  • Table 97 : MEA Market for Drug Discovery Technologies, by Application, Through 2029
  • Table 98 : MEA Market for Drug Discovery Technologies, by End User, Through 2029
  • Table 99 : Focus Areas in ESG Metrics
  • Table 100 : ESG Rankings for Drug Discovery Technologies, as of May 2024
  • Table 101 : Abbreviations Used in this Report
  • Table 102 : Report Sources
  • Table 103 : Agilent Technologies Inc.: Company Snapshot
  • Table 104 : Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
  • Table 105 : Agilent Technologies Inc.: Product Portfolio
  • Table 106 : Agilent Technologies Inc.: News/Key Development, 2024
  • Table 107 : Bio-Rad Laboratories Inc.: Company Snapshot
  • Table 108 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
  • Table 109 : Bio-Rad Laboratories Inc.: Product Portfolio
  • Table 110 : Bio-Rad Laboratories Inc.: News/Key Developments, 2024
  • Table 111 : Bruker: Company Snapshot
  • Table 112 : Bruker: Financial Performance, FY 2022 and 2023
  • Table 113 : Bruker: Product Portfolio
  • Table 114 : Bruker: News/Key Developments, 2024
  • Table 115 : Charles River Laboratories: Company Snapshot
  • Table 116 : Charles River Laboratories: Financial Performance, FY 2022 and 2023
  • Table 117 : Charles River Laboratories: Service Portfolio
  • Table 118 : Danaher Corp.: Company Snapshot
  • Table 119 : Danaher Corp.: Financial Performance, FY 2022 and 2023
  • Table 120 : Danaher Corp.: Product Portfolio
  • Table 121 : Danaher Corp.: News/Key Developments, 2022
  • Table 122 : Illumina: Company Snapshot
  • Table 123 : Illumina: Financial Performance, FY 2022 and 2023
  • Table 124 : Illumina: Product Portfolio
  • Table 125 : Promega Corp.: Company Snapshot
  • Table 126 : Promega Corp.: Product Portfolio
  • Table 127 : Qiagen: Company Snapshot
  • Table 128 : Qiagen: Financial Performance, FY 2022 and 2023
  • Table 129 : Qiagen: Product Portfolio
  • Table 130 : Qiagen: News/Key Developments, 2024
  • Table 131 : Revvity: Company Snapshot
  • Table 132 : Revvity: Financial Performance, FY 2022 and 2023
  • Table 133 : Revvity: Product Portfolio
  • Table 134 : Thermo Fisher Scientific Inc.: Company Snapshot
  • Table 135 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
  • Table 136 : Thermo Fisher Scientific Inc.: Product Portfolio
  • Table 137 : Thermo Fisher Scientific Inc.: News/Key Developments, 2024

List of Figures

  • Summary Figure : Global Market for Drug Discovery Technologies, by Technology, 2021-2029
  • Figure 1 : Snapshot of the Market Dynamics for Drug Discovery Technologies
  • Figure 2 : Most Frequent Cancer Types in Women, 2022
  • Figure 3 : Most Frequent Cancer Types in Men, 2022
  • Figure 4 : Share of Population Aged 65 and Older in G7 Countries, 2021
  • Figure 5 : Regional Shares of Population Aged 65+, 2016 and 2050
  • Figure 6 : Total Stem Cell Research Funding by the NIH, 2013-2024
  • Figure 7 : Process of Drug Discovery
  • Figure 8 : Global Market Shares of Drug Discovery Technologies, by Technology, 2023
  • Figure 9 : Global Market for HTS in Drug Discovery, by Region, 2021-2029
  • Figure 10 : Global Market for Bioanalytical Instruments in Drug Discovery, by Region, 2021-2029
  • Figure 11 : Global Market Shares of Genomics in Drug Discovery, by Region, 2023
  • Figure 12 : Global Market Shares of Proteomics in Drug Discovery, by Region, 2023
  • Figure 13 : Global Market Shares of Cell-based Assays and Reagents in Drug Discovery, by Region, 2023
  • Figure 14 : Global Market Shares of Bioinformatics in Drug Discovery, by Region, 2023
  • Figure 15 : Global Market Shares of Other Technologies in Drug Discovery, by Region, 2023
  • Figure 16 : Global Market Shares of Drug Discovery Technologies, by Application, 2023
  • Figure 17 : Global Market Shares of Drug Discovery Technologies in Oncology, by Region, 2023
  • Figure 18 : Global Market Shares of Drug Discovery Technologies in Cardiology, by Region, 2023
  • Figure 19 : Global Market Shares of Drug Discovery Technologies in Neurodegenerative Diseases, by Region, 2023
  • Figure 20 : Global Market Shares of Drug Discovery Technologies in Immunological Diseases, by Region, 2023
  • Figure 21 : Global Market Shares of Drug Discovery Technologies in Other Diseases, by Region, 2023
  • Figure 22 : Global Market Shares of Drug Discovery Technologies, by End User, 2023
  • Figure 23 : Global Market Shares of Drug Discovery Technologies in Biopharma Companies, by Region, 2023
  • Figure 24 : Global Market Shares of Drug Discovery Technologies in Research and Academia, by Region, 2023
  • Figure 25 : Global Market Shares of Drug Discovery Technologies in CROs, by Region, 2023
  • Figure 26 : Global Market for Drug Discovery Technologies, by Region, 2021-2029
  • Figure 27 : North American Market for Drug Discovery Technologies, by Product Type, 2021-2029
  • Figure 28 : North American Market for Drug Discovery Technologies, by Application, 2021-2029
  • Figure 29 : North American Market for Drug Discovery Technologies, by End User, 2021-2029
  • Figure 30 : North American Market Shares of Drug Discovery Technologies, by Country, 2023
  • Figure 31 : U.S. Market for Drug Discovery Technologies, by Technology, 2021-2029
  • Figure 32 : U.S. Market for Drug Discovery Technologies, by Application, 2021-2029
  • Figure 33 : U.S. Market for Drug Discovery Technologies, by End User, 2021-2029
  • Figure 34 : Canadian Market for Drug Discovery Technologies, by Technology, 2021-2029
  • Figure 35 : Canadian Market for Drug Discovery Technologies, by Application, 2021-2029
  • Figure 36 : Canadian Market for Drug Discovery Technologies, by End User, 2021-2029
  • Figure 37 : Mexican Market for Drug Discovery Technologies, by Technology, 2021-2029
  • Figure 38 : Mexican Market for Drug Discovery Technologies, by Application, 2021-2029
  • Figure 39 : Mexican Market for Drug Discovery Technologies, by End User, 2021-2029
  • Figure 40 : European Market for Drug Discovery Technologies, by Technology, 2021-2029
  • Figure 41 : European Market for Drug Discovery Technologies, by Application, 2021-2029
  • Figure 42 : European Market for Drug Discovery Technologies, by End User, 2021-2029
  • Figure 43 : European Market Shares of Drug Discovery Technologies, by Country, 2023
  • Figure 44 : German Market for Drug Discovery Technologies, by Technology, 2021-2029
  • Figure 45 : German Market for Drug Discovery Technologies, by Application, 2021-2029
  • Figure 46 : German Market for Drug Discovery Technologies, by End User, 2021-2029
  • Figure 47 : U.K. Market for Drug Discovery Technologies, by Technology, 2021-2029
  • Figure 48 : U.K. Market for Drug Discovery Technologies, by Application, 2021-2029
  • Figure 49 : U.K. Market for Drug Discovery Technologies, by End User, 2021-2029
  • Figure 50 : French Market for Drug Discovery Technologies, by Technology, 2021-2029
  • Figure 51 : French Market for Drug Discovery Technologies, by Application, 2021-2029
  • Figure 52 : French Market for Drug Discovery Technologies, by End User, 2021-2029
  • Figure 53 : Italian Market for Drug Discovery Technologies, by Technology, 2021-2029
  • Figure 54 : Italian Market for Drug Discovery Technologies, by Application, 2021-2029
  • Figure 55 : Italian Market for Drug Discovery Technologies, by End User, 2021-2029
  • Figure 56 : Spanish Market for Drug Discovery Technologies, by Technology, 2021-2029
  • Figure 57 : Spanish Market for Drug Discovery Technologies, by Application, 2021-2029
  • Figure 58 : Spanish Market for Drug Discovery Technologies, by End User, 2021-2029
  • Figure 59 : Rest of Europe Market for Drug Discovery Technologies, by Technology, 2021-2029
  • Figure 60 : Rest of Europe Market for Drug Discovery Technologies, by Application, 2021-2029
  • Figure 61 : Rest of Europe Market for Drug Discovery Technologies, by End User, 2021-2029
  • Figure 62 : Asia-Pacific Market for Drug Discovery Technologies, by Technology, 2021-2029
  • Figure 63 : Asia-Pacific Market for Drug Discovery Technologies, by Application, 2021-2029
  • Figure 64 : Asia-Pacific Market for Drug Discovery Technologies, by End User, 2021-2029
  • Figure 65 : Asia-Pacific Market Shares of Drug Discovery Technologies, by Country, 2023
  • Figure 66 : Chinese Market for Drug Discovery Technologies, by Technology, 2021-2029
  • Figure 67 : Chinese Market for Drug Discovery Technologies, by Application, 2021-2029
  • Figure 68 : Chinese Market for Drug Discovery Technologies, by End User, 2021-2029
  • Figure 69 : Japanese Market for Drug Discovery Technologies, by Technology, 2021-2029
  • Figure 70 : Japanese Market for Drug Discovery Technologies, by Application, 2021-2029
  • Figure 71 : Japanese Market for Drug Discovery Technologies, by End User, 2021-2029
  • Figure 72 : Indian Market for Drug Discovery Technologies, by Technology, 2021-2029
  • Figure 73 : Indian Market for Drug Discovery Technologies, by Application, 2021-2029
  • Figure 74 : Indian Market for Drug Discovery Technologies, by End User, 2021-2029
  • Figure 75 : South Korean Market for Drug Discovery Technologies, by Technology, 2021-2029
  • Figure 76 : South Korean Market for Drug Discovery Technologies, by Application, 2021-2029
  • Figure 77 : South Korean Market for Drug Discovery Technologies, by End User, 2021-2029
  • Figure 78 : Australian Market for Drug Discovery Technologies, by Technology, 2021-2029
  • Figure 79 : Australian Market for Drug Discovery Technologies, by Application, 2021-2029
  • Figure 80 : Australian Market for Drug Discovery Technologies, by End User, 2021-2029
  • Figure 81 : Rest of Asia-Pacific Market for Drug Discovery Technologies, by Technology, 2021-2029
  • Figure 82 : Rest of Asia-Pacific Market for Drug Discovery Technologies, by Application, 2021-2029
  • Figure 83 : Rest of Asia-Pacific Market for Drug Discovery Technologies, by End User, 2021-2029
  • Figure 84 : RoW Market for Drug Discovery Technologies, by Technology, 2021-2029
  • Figure 85 : RoW Market for Drug Discovery Technologies, by Application, 2021-2029
  • Figure 86 : RoW Market for Drug Discovery Technologies, by End User, 2021-2029
  • Figure 87 : RoW Market Shares of Drug Discovery Technologies, by Sub-Region, 2023
  • Figure 88 : South American Market for Drug Discovery Technologies, by Technology, 2021-2029
  • Figure 89 : South American Market for Drug Discovery Technologies, by Application, 2021-2029
  • Figure 90 : South American Market for Drug Discovery Technologies, by End User, 2021-2029
  • Figure 91 : MEA Market for Drug Discovery Technologies, by Technology, 2021-2029
  • Figure 92 : MEA Market for Drug Discovery Technologies, by Application, 2021-2029
  • Figure 93 : MEA Market for Drug Discovery Technologies, by End User, 2021-2029
  • Figure 94 : Global Market Shares of Drug Discovery Technologies, by Company, 2023
  • Figure 95 : SWOT Analysis of the Drug Discovery Technologies Market
  • Figure 96 : Pillars of ESG
  • Figure 97 : Benefits of ESG for Companies
  • Figure 98 : Global ESG-Adoption Level Across All Industries, 2021 and 2022
  • Figure 99 : Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2023
  • Figure 100 : Agilent Technologies Inc.: Revenue Share, by Region, FY 2023
  • Figure 101 : Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2023
  • Figure 102 : Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2023
  • Figure 103 : Bruker: Revenue Share, by Business Unit, FY 2023
  • Figure 104 : Bruker: Revenue Share, by Country/Region, FY 2023
  • Figure 105 : Charles River Laboratories: Revenue Share, by Business Unit, FY 2023
  • Figure 106 : Charles River Laboratories: Revenue Share, by Country/Region, FY 2023
  • Figure 107 : Danaher Corp.: Revenue Share, by Business Unit, FY 2023
  • Figure 108 : Danaher Corp.: Revenue Share, by Country/Region, FY 2023
  • Figure 109 : Illumina: Revenue Share, by Business Unit, FY 2023
  • Figure 110 : Illumina: Revenue Share, by Country/Region, FY 2023
  • Figure 111 : Qiagen: Market Share, by Business Unit, FY 2023
  • Figure 112 : Qiagen: Revenue Share, by Region, FY 2023
  • Figure 113 : Revvity: Revenue Share, by Business Unit, FY 2023
  • Figure 114 : Revvity: Revenue Share, by Region, FY 2023
  • Figure 115 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023
  • Figure 116 : Thermo Fisher Scientific Inc.: Revenue Share, by Region, FY 2023